Abstract
BackgroundThe use of non-biologic disease-modifying anti-rheumatic drugs (DMARDs) has been scarcely explored in patients with IgG4-related disease (IgG4-RD). There is only one small series reporting the use of methotrexate.ObjectivesThis paper...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
